Contributor Page
Patterson Belknap Webb & Tyler LLP
Email  |  Articles
Contact Details
Tel: +1 212 3362000
Fax: +1 212 3362222
1133 Avenue of the Americas
New York
10036 6710
United States
By Kathrina Szymborski, William Cavanaugh
European competition authorities announced this week an investigation into Aspen Pharmacare's recent price hikes of five cancer drugs.
By David Kleban, Deirdre McEvoy
New York Attorney General Eric Schneiderman is reportedly investigating the National Football League for antitrust violations in connection with its imposition of "price floors" on tickets for resale.
By Megan Bell, Lauren Simpson
Since enactment of the PATH Act on December 18, 2015, exempt organizations have been waiting for IRS guidance on the new Section 501(c)(4) notification requirement and procedures for organizations...
By Jonathan Hatch, Jake Walter-Warner
Defendants in the In re Cathode Ray Tube Antitrust Litigation moved to challenge the standing of major retailers to pursue damages claims under the Supreme Court's 1977 Illinois Brick decision.
By Nathan Monroe-Yavneh, Aron Fischer
Amgen has decided not to seek Supreme Court review of the Federal Circuit's Amgen v. Sandoz decision, as the January 14, 2016 deadline to file has now passed without Amgen petitioning for certiorari.
By Deirdre McEvoy, Jake Walter-Warner
The court explicitly held that evidence of market manipulation by a dominant player in a commodities market could be enough to prove market power.
By Andrew Cohen, Irena Royzman
In Amgen v. Apotex, Judge Cohn of the Southern District of Florida recently enjoined Apotex from selling its proposed biosimilar of Amgen's Neulasta for 180 days following FDA approval.
By Deirdre McEvoy, Jake Walter-Warner
The lawsuit, one of several arising from the Apple-AT&T agreement, raises interesting questions about how to define a relevant product market using an "aftermarket" theory.
By Megan Bell, Susan Vignola
On December 11, 2015 Governor Andrew M. Cuomo signed into a law a bill amending New York's Not-for-Profit Corporation Law (the "NPCL")...
By Deirdre McEvoy, Kathrina Szymborski
The market the FTC defined in its complaint—sale and distribution of consumable office supplies to large, business-to-business customers—is distinct from the retail market for office supplies sold to consumers.
By Aron Fischer
On December 9, a federal district court in Florida issued a preliminary injunction prohibiting Apotex from selling a proposed biosimilar version of Amgen's cancer drug Neulasta for 180 days after the biosimilar is approved.
By Dahlia Doumar, Justin Zaremby
In April of this year, the Financial Accounting Standards Board ("FASB") circulated a series of proposed changes to generally accepted accounting principles ("GAAP") applicable to certain not-for-profits.
By Aron Fischer, Jacob Siegel
This fall marks the tenth anniversary of the effective date of the European Medicines Agency's Guideline on Similar Biological Medicinal Products.
By Deirdre McEvoy, Amy Vegari
On November 25, 2015, the Court of Appeals for the Fifth Circuit affirmed the $156 million antitrust judgment in MM Steel, L.P. v. JSW Steel (USA) Incorporated; Nucor Corporation.
By Jillian Diamant, Tomer Inbar
The IRS is considering eliminating Schedule B of the Form 990, which asks for the names and addresses of an exempt organization's contributors and for certain information about contributions received.
Contributor's Topics